{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:24:44Z","timestamp":1789680284778,"version":"4.0.1"},"reference-count":269,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["22YF7WA013"],"award-info":[{"award-number":["22YF7WA013"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009620","name":"Science and Technology Department of Gansu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018554","name":"Science and Technology Program of Gansu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biopha.2024.116271","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T20:00:25Z","timestamp":1716494425000},"page":"116271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects"],"prefix":"10.1016","volume":"176","author":[{"given":"Zonghao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116271_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105302","article-title":"Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities","volume":"163","author":"Lal","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2024.116271_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106267","article-title":"Biological effects of cannabidiol on human cancer cells: Systematic review of the literature","volume":"181","author":"Valenti","year":"2022","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr. Drug Saf."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","article-title":"Chemical constituents of marijuana: the complex mixture of natural cannabinoids","volume":"78","author":"Elsohly","year":"2005","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.biopha.2024.116271_bib5","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1167\/iovs.08-2196","article-title":"Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor","volume":"49","author":"Liou","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2024.116271_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1472-6882-10-77","article-title":"Oxidative DNA damage preventive activity and antioxidant potential of plants used in Unani system of medicine","volume":"10","author":"Kalim","year":"2010","journal-title":"BMC Complement Alter. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-8-5","article-title":"Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study","volume":"8","author":"Ruiz-Valdepe\u00f1as","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2024.116271_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2024.116271_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","article-title":"The non-psychoactive Cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain","volume":"556","author":"Costa","year":"2007","journal-title":"Eur. J. Pharm."},{"issue":"S1","key":"10.1016\/j.biopha.2024.116271_bib11","doi-asserted-by":"crossref","first-page":"417S","DOI":"10.1002\/j.1552-4604.1981.tb02622.x","article-title":"Hypnotic and antiepileptic effects of cannabidiol","volume":"21","author":"Carlini","year":"1981","journal-title":"J. Clin. Pharm."},{"issue":"2-3","key":"10.1016\/j.biopha.2024.116271_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/rej.2009.0993","article-title":"Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications","volume":"13","author":"Candore","year":"2010","journal-title":"Rejuvenat. Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.bjp.0705920","article-title":"Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation","volume":"143","author":"Costa","year":"2004","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116271_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.07.003","article-title":"N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice","volume":"89","author":"Ciaglia","year":"2014","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14737175.8.1.37","article-title":"Cannabinoids as potential new therapy for the treatment of gliomas","volume":"8","author":"Parolaro","year":"2008","journal-title":"Expert Rev. Neurother."},{"issue":"12","key":"10.1016\/j.biopha.2024.116271_bib16","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ptr.2806","article-title":"Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress","volume":"23","author":"Comelli","year":"2009","journal-title":"Phytother. Res"},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J. Pain. Symptom Manag."},{"issue":"17","key":"10.1016\/j.biopha.2024.116271_bib18","doi-asserted-by":"crossref","first-page":"9561","DOI":"10.1073\/pnas.160105897","article-title":"The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis","volume":"97","author":"Malfait","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"20","key":"10.1016\/j.biopha.2024.116271_bib19","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib20","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/np8002673","article-title":"Antibacterial cannabinoids from Cannabis sativa: a structure-activity study","volume":"71","author":"Appendino","year":"2008","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2024.116271_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: state of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharm. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.phrs.2009.03.008","article-title":"Cannabinoids in intestinal inflammation and cancer","volume":"60","author":"Izzo","year":"2009","journal-title":"Pharm. Res"},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-010-1177-4","article-title":"Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis","volume":"129","author":"McAllister","year":"2011","journal-title":"Breast Cancer Res Treat."},{"issue":"7","key":"10.1016\/j.biopha.2024.116271_bib25","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-013-1277-1","article-title":"Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas","volume":"116","author":"Rocha","year":"2014","journal-title":"J. Neurooncol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tips.2013.03.003","article-title":"The endocannabinoid signaling system in cancer","volume":"34","author":"Pisanti","year":"2013","journal-title":"Trends Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bcp.2014.06.017","article-title":"Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells","volume":"91","author":"Ramer","year":"2014","journal-title":"Biochem Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2024.116271_bib29","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/1535-7163.MCT-14-0402","article-title":"The combination of cannabidiol and \u03949-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma mode","volume":"13","author":"Scott","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s42003-020-01530-y","article-title":"The antimicrobial potential of cannabidiol","volume":"4","author":"Blaskovich","year":"2021","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000443890","article-title":"Effect of cannabidiol in a rat model of depression","volume":"73","author":"Shoval","year":"2016","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2011.08.013","article-title":"Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats","volume":"62","author":"Hsiao","year":"2012","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","article-title":"Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L","volume":"95","author":"El-Alfy","year":"2010","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.biopha.2024.116271_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbr.2015.02.023","article-title":"Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: contribution of 5HT\u2081A receptors and stressful experiences","volume":"286","author":"Marinho","year":"2015","journal-title":"Behav. Brain Res"},{"issue":"6","key":"10.1016\/j.biopha.2024.116271_bib35","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/1871527313666140612114838","article-title":"Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa","volume":"13","author":"de Mello Schier","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib36","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.pnpbp.2006.06.004","article-title":"Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test","volume":"30","author":"Moreira","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2009.09.045","article-title":"Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats","volume":"207","author":"Lemos","year":"2010","journal-title":"Behav.Brain Res"},{"key":"10.1016\/j.biopha.2024.116271_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pnpbp.2012.10.024","article-title":"Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test","volume":"41","author":"Almeida","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"32","key":"10.1016\/j.biopha.2024.116271_bib39","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.2174\/138161212802884681","article-title":"A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation","volume":"18","author":"Zuardi","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"1-3","key":"10.1016\/j.biopha.2024.116271_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","article-title":"Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol","volume":"164","author":"Gomes","year":"2015","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib41","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2174\/1871527314666150909113930","article-title":"Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis","volume":"14","author":"Crippa","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00406-019-00982-6","article-title":"Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms","volume":"269","author":"Crippa","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116271_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib46","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series","volume":"39","author":"Chagas","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib47","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1074\/jbc.M109.069294","article-title":"Cannabinoids Delta(9) -tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta\/STAT proinflammatory pathways in BV-2 microglial cells","volume":"285","author":"Kozela","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.biopha.2024.116271_bib48","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"Rajesh","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2007.06.029","article-title":"Cannabidiol arrests onset of autoimmune diabetes in NOD mice","volume":"54","author":"Weiss","year":"2008","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/08916930500356674","article-title":"Cannabidiol lowers incidence of diabetes in non-obese diabetic mice","volume":"39","author":"Weiss","year":"2006","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.biopha.2024.116271_bib51","doi-asserted-by":"crossref","first-page":"H3602","DOI":"10.1152\/ajpheart.00098.2007","article-title":"Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury","volume":"293","author":"Durst","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib52","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","article-title":"Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress","volume":"51","author":"Booz","year":"2011","journal-title":"Free Radic. Biol. Med"},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2125.2012.04351.x","article-title":"Is the cardiovascular system a therapeutic target for cannabidiol","volume":"75","author":"Stanley","year":"2013","journal-title":"Br. J. Clin. Pharm."},{"issue":"15","key":"10.1016\/j.biopha.2024.116271_bib54","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u2206E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacol. (Berl. )"},{"issue":"7","key":"10.1016\/j.biopha.2024.116271_bib55","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother. Res"},{"issue":"6","key":"10.1016\/j.biopha.2024.116271_bib56","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol. Pharm."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116271_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement","volume":"399","author":"Esposito","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib58","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt\/beta-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J. Mol. Med (Berl. )"},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib59","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1471-4159.2007.04565.x","article-title":"Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism","volume":"102","author":"Hayakawa","year":"2007","journal-title":"J. Neurochem"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib60","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s11259-010-9379-0","article-title":"Immunohistochemical localization of CB1 receptor in canine salivary glands","volume":"34","author":"Dall'Aglio","year":"2010","journal-title":"Vet. Res Commun."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib61","doi-asserted-by":"crossref","first-page":"e870","DOI":"10.1111\/jpn.12848","article-title":"The presence and distribution of cannabinoid type 1 and 2 receptors in the mandibular gland: the influence of different physical forms of diets on their expression in piglets","volume":"102","author":"Pirino","year":"2018","journal-title":"J. Anim. Physiol. Anim. Nutr. (Berl. )"},{"issue":"11","key":"10.1016\/j.biopha.2024.116271_bib62","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jocn.2010.04.005","article-title":"Cannabinoid receptor CB1-immunoreactive nerve fibres in painful and non-painful human tooth pulp","volume":"17","author":"Beneng","year":"2010","journal-title":"J. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib63","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.joen.2016.10.004","article-title":"Expression of cannabinoid type 1 receptors in human odontoblast cells","volume":"43","author":"Que","year":"2017","journal-title":"J. Endod."},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib64","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s10571-017-0482-4","article-title":"In vivo and in vitro identification of endocannabinoid signaling in periodontal tissues and their potential role in local pathophysiology","volume":"37","author":"Konermann","year":"2017","journal-title":"Cell Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib65","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.biopha.2024.116271_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-21737-2_1","article-title":"Endocannabinoid system components: overview and tissue distribution","volume":"1162","author":"Joshi","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib67","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib68","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib69","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib70","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvp240","article-title":"CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages","volume":"84","author":"Han","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"25","key":"10.1016\/j.biopha.2024.116271_bib71","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M111.335273","article-title":"Cannabinoid receptors CB1 and CB2 form functional heteromers in brain","volume":"287","author":"Call\u00e9n","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"48","key":"10.1016\/j.biopha.2024.116271_bib72","article-title":"A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis","volume":"23","author":"Giacoppo","year":"2015","journal-title":"Daru"},{"key":"10.1016\/j.biopha.2024.116271_bib73","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.biopha.2024.116271_bib74","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3390\/molecules28073271","article-title":"The polypharmacological effects of cannabidiol","volume":"28","author":"Castillo-Arellano","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116271_bib75","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejphar.2019.04.050","article-title":"G-protein coupled receptor 55 agonists increase insulin secretion through inositol trisphosphate-mediated calcium release in pancreatic \u03b2-cells","volume":"854","author":"Vong","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116271_bib76","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biopha.2017.12.056","article-title":"Orphan G protein-coupled receptors: the role in CNS disorders","volume":"98","author":"Alavi","year":"2018","journal-title":"Biomed. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib77","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/1570159X14666160729155441","article-title":"Advances in the physiology of GPR55 in the central nervous system","volume":"15","author":"Marichal-Cancino","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib78","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41401-018-0031-9","article-title":"GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol","volume":"40","author":"Laun","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"1-3","key":"10.1016\/j.biopha.2024.116271_bib79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2009.03.010","article-title":"Time-dependent vascular actions of cannabidiol in the rat aorta","volume":"612","author":"O\u2019Sullivan","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116271_bib80","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/abbs\/gmx073","article-title":"Effects of cannabidiol interactions with Wnt\/\u03b2-catenin pathway and PPAR\u03b3 on oxidative stress and neuroinflammation in Alzheimer\u2019s disease","volume":"49","author":"Vall\u00e9e","year":"2017","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"12","key":"10.1016\/j.biopha.2024.116271_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2024.116271_bib82","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.fitote.2016.11.010","article-title":"Target regulation of PI3K\/Akt\/MTOR pathway by cannabidiol in treatment of experimental multiple sclerosis","volume":"116","author":"Giacoppo","year":"2017","journal-title":"Fitoterapia"},{"issue":"12","key":"10.1016\/j.biopha.2024.116271_bib83","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O'Sullivan","year":"2016","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116271_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.615811","article-title":"An analysis of the putative CBD binding site in the ionotropic cannabinoid receptors","volume":"14","author":"Muller","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/medicines5030059","article-title":"Pain modulation after oromucosal cannabinoid spray (SATIVEX\u00ae) in patients with multiple sclerosis: a study with quantitative sensory testing and laser-evoked potentials","volume":"5","author":"Turri","year":"2018","journal-title":"Medicines"},{"issue":"7","key":"10.1016\/j.biopha.2024.116271_bib86","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.biopha.2024.116271_bib87","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1523\/JNEUROSCI.0504-08.2008","article-title":"TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons","volume":"28","author":"Qin","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2024.116271_bib88","article-title":"Molecular mechanism of TRPV2 channel modulation by cannabidiol","volume":"8","author":"Pumroy","year":"2019","journal-title":"EIife"},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib89","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1748-1716.2011.02338.x","article-title":"Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation","volume":"204","author":"De Petrocellis","year":"2012","journal-title":"Acta Physiol. (Oxf. )"},{"key":"10.1016\/j.biopha.2024.116271_bib90","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.lfs.2018.08.050","article-title":"Serotonin receptors in depression and anxiety: insights from animal studies","volume":"210","author":"\u017bmudzka","year":"2018","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib91","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib92","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2024.116271_bib93","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2024.116271_bib94","article-title":"Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death","volume":"412","author":"Rimmerman","year":"2013","journal-title":"Cell Death Dis."},{"issue":"43","key":"10.1016\/j.biopha.2024.116271_bib95","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1074\/jbc.RA118.004929","article-title":"Inhibitory effects of cannabidiol on voltage-dependent sodium currents","volume":"293","author":"Ghovanloo","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2024.116271_bib96","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1021\/acs.jnatprod.0c00138","article-title":"Inhibitory effect of cannabidiol on the activation of NLRP3 inflammasome is associated with its modulation of the P2\u00d77 receptor in human monocytes","volume":"83","author":"Liu","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib97","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1124\/dmd.109.026930","article-title":"Cannabidiol-2\u2032, 6\u2032-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitor","volume":"37","author":"Takeda","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2024.116271_bib98","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/medicina56110607","article-title":"Cannabidiol and vitamin D3 impact on osteogenic differentiation of human dental mesenchymal stem cells","volume":"56","author":"Petrescu","year":"2020","journal-title":"Medicina"},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib99","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tips.2009.05.004","article-title":"The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities","volume":"30","author":"B\u00edr\u00f3","year":"2009","journal-title":"Trends Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib100","first-page":"523","article-title":"Epithelial expression of vanilloid and cannabinoid receptors: a potential role in burning mouth syndrome pathogenesis","volume":"29","author":"Borsani","year":"2014","journal-title":"Histol. Histopathol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib101","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.semcdb.2012.08.004","article-title":"Modulation of sweet responses of taste receptor cells","volume":"24","author":"Yoshida","year":"2013","journal-title":"Semin Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116271_bib102","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.bcp.2004.06.029","article-title":"Expression and biological effects of CB1 cannabinoid receptor in rat parotid gland","volume":"68","author":"Busch","year":"2004","journal-title":"Biochem Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2024.116271_bib103","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/jcpe.13190","article-title":"Activation of cannabinoid receptors promote periodontal cell adhesion and migration","volume":"46","author":"Liu","year":"2019","journal-title":"J. Clin. Periodo"},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib104","first-page":"523","article-title":"Epithelial expression of vanilloid and cannabinoid receptors: a potential role in burning mouth syndrome pathogenesis","volume":"29","author":"Borsani","year":"2014","journal-title":"Histol. Histopathol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116271_bib105","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/odi.13246","article-title":"The effects of cannabis use on oral health","volume":"26","author":"Liu","year":"2020","journal-title":"Oral. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib106","first-page":"523","article-title":"Epithelial expression of vanillin and cannabinoid receptors: a potential role in the pathogenesis of burning mouth syndrome","volume":"29","author":"Borsani","year":"2014","journal-title":"Histol. Histopathol."},{"issue":"36","key":"10.1016\/j.biopha.2024.116271_bib107","doi-asserted-by":"crossref","first-page":"33896","DOI":"10.1074\/jbc.M303994200","article-title":"The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase","volume":"278","author":"Maccarrone","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib108","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1601-0825.2009.01526.x","article-title":"Increased expression of TRPV1 in squamous cell carcinoma of the human tongue","volume":"15","author":"Marincsak","year":"2009","journal-title":"Oral. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib109","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1007\/s13277-015-4182-8","article-title":"Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival","volume":"37","author":"Theocharis","year":"2016","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1158\/1055-9965.EPI-13-0181","article-title":"Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium","volume":"23","author":"Marks","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib111","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11914-020-00607-1","article-title":"The cannabinoids effect on bone formation and bone healing","volume":"18","author":"Rafael Mizrahi","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.biopha.2024.116271_bib112","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.archoralbio.2017.05.003","article-title":"Immunohistochemical localization of cannabinoid receptor 1 (CB1) in the submandibular gland of mice under normal conditions and when stimulated by isoproterenol or carbachol","volume":"81","author":"Thoungseabyoun","year":"2017","journal-title":"Arch. Oral. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib113","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharm. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib114","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1073\/pnas.0912048107","article-title":"Endocannabinoids selectively enhance sweet taste","volume":"107","author":"Yoshida","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.biopha.2024.116271_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107407","article-title":"Endocannabinoids and inflammatory response in periodontal ligament cells","volume":"9","author":"\u00d6zdemir","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib116","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s40496-014-0044-5","article-title":"The biofilm community: rebels with a cause","volume":"2","author":"Aruni","year":"2015","journal-title":"Curr. Oral. Heal Rep."},{"issue":"23","key":"10.1016\/j.biopha.2024.116271_bib117","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.5897\/AJMR2015.7457","article-title":"Oral microflora of supragingival and subgingival biofilms in Algerian healthy adults","volume":"9","author":"Sara","year":"2015","journal-title":"Afr. J. Microbiol Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib118","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s42238-020-00027-z","article-title":"Cannabinoids infused mouthwash products are as effective as chlorhexidine on inhibition of total-culturable bacterial content in dental plaque samples","volume":"2","author":"Vasudevan","year":"2020","journal-title":"J. Cannabis Res"},{"key":"10.1016\/j.biopha.2024.116271_bib119","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3389\/fonc.2019.01087","article-title":"Inflammation, cancer and immunity\u2014implication of TRPV1 channel","volume":"9","author":"Bujak","year":"2019","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib120","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/jpet.117.244368","article-title":"Anti-inflammatory properties of cannabidiol, a nonpsychotropic cannabinoid, in experimental allergic contact dermatitis","volume":"365","author":"Petrosino","year":"2018","journal-title":"J. Pharm. Exp. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib121","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211002695","article-title":"Nexus between COVID-19 and periodontal disease","volume":"49","author":"Sukumar","year":"2021","journal-title":"J. Int. Med. Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib122","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.intimp.2008.11.010","article-title":"Cannabidiol decreases bone resorption by inhibiting RANK\/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats","volume":"9","author":"Napimoga","year":"2009","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.116271_bib123","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116271_bib124","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","article-title":"Cannabinoid ligands targeting TRP channels","volume":"11","author":"Muller","year":"2008","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2024.116271_bib125","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3389\/fonc.2019.01087","article-title":"Inflammation, cancer and immunity\u2014implication of TRPV1 channel","volume":"9","author":"Bujak","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2024.116271_bib126","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ncomms2270","article-title":"PPAR\u03b3 is an E3 ligase that induces the degradation of NF\u03baB\/p65","volume":"3","author":"Hou","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116271_bib127","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2008.04.006","article-title":"The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain","volume":"139","author":"Staton","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2024.116271_bib128","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/cr.2011.60","article-title":"GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils","volume":"21","author":"Balenga","year":"2011","journal-title":"Cell Res"},{"issue":"9","key":"10.1016\/j.biopha.2024.116271_bib129","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bpj.2017.03.037","article-title":"Antioxidant and membrane binding properties of serotonin protect lipids from oxidation","volume":"112","author":"Azouzi","year":"2017","journal-title":"Biophys. J."},{"key":"10.1016\/j.biopha.2024.116271_bib130","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.2174\/0929867325666180313110254","article-title":"A2A adenosine receptor agonists and their potential therapeutic applications, an update","volume":"25","author":"Guerrero","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116271_bib131","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/jpet.300.1.200","article-title":"KF24345, an adenosine uptake inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production and leukopenia via endogenous adenosine in mice","volume":"300","author":"Noji","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2024.116271_bib132","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2003.11.003","article-title":"Adenosine: An endogenous regulator of innate immunity","volume":"25","author":"Hask\u00f3","year":"2004","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116271_bib133","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/microorganisms9102031","article-title":"Anti-biofilm activity of cannabigerol against Streptococcus mutans","volume":"9","author":"Aqawi","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2024.116271_bib134","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jdent.2019.05.022","article-title":"Vital pulp therapy: histopathology and histobacteriology-based guidelines to treat teeth with deep caries and pulp exposure","volume":"86","author":"Ricucci Siqueira","year":"2019","journal-title":"J. Dent."},{"key":"10.1016\/j.biopha.2024.116271_bib135","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3389\/fphar.2018.01259","article-title":"Cannabinoids and pain: new insights from old molecules","volume":"9","author":"Vu\u010dkovi\u0107","year":"2018","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib136","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.joen.2016.10.004","article-title":"Expression of cannabinoid type 1 receptors in human odontoblast cells","volume":"43","author":"Que","year":"2017","journal-title":"J. Endod."},{"key":"10.1016\/j.biopha.2024.116271_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdent.2021.103673","article-title":"Investigation of in vitro odonto\/osteogenic capacity of cannabidiol on human dental pulp cell","volume":"109","author":"Qi","year":"2021","journal-title":"J. Dent."},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib138","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3390\/ijms19082341","article-title":"Treatment of periodontal ligament stem cells with MOR and CBD promotes cell survival and neuronal differentiation via the PI3K\/Akt\/mTOR pathway","volume":"19","author":"Lanza Cariccio","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib139","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/microorganisms9020441","article-title":"Anti-biofilm activity of cannabidiol against Candida albicans","volume":"9","author":"Feldman","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2024.116271_bib140","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.bmc.2015.01.059","article-title":"Cannabidiol (CBD) and its analogs: a review of their effects on inflammation","volume":"23","author":"Burstein","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116271_bib141","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1111\/j.1476-5381.2011.01519.x","article-title":"Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro","volume":"165","author":"Whyte","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116271_bib142","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3390\/antiox10050738","article-title":"New insights on hemp oil enriched in cannabidiol: decarboxylation, antioxidant properties and in vitro anticancer effect","volume":"10","author":"Petrovici","year":"2021","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib143","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000510256","article-title":"Cannabidiol (CBD) oil does not display an entourage effect in reducing cancer cell viability in vitro","volume":"3","author":"Raup-Konsavage","year":"2020","journal-title":"Med. Cannabis Cannabinoids"},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib144","first-page":"566","article-title":"Different Cannabis sativa extraction methods result in different biological activities against a colon cancer cell line and healthy colon cells","volume":"10","author":"Ro\u017eanc","year":"2021","journal-title":"Plants (Basel)"},{"issue":"15","key":"10.1016\/j.biopha.2024.116271_bib145","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.3390\/ijms21155533","article-title":"Cytotoxic effects of cannabinoids on human HT-29 colorectal adenocarcinoma cells: different mechanisms of THC, CBD, and CB83","volume":"21","author":"Cerretani","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib146","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13104-020-05229-5","article-title":"Anti-proliferative and cytotoxic effect of cannabidiol on human cancer cell lines in presence of serum","volume":"13","author":"Sainz-Cort","year":"2020","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib147","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bph.13345","article-title":"GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis","volume":"173","author":"Kargl","year":"2016","journal-title":"Br. J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib148","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.phymed.2013.11.006","article-title":"Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol","volume":"21","author":"Romano","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2024.116271_bib149","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2019.01.011","article-title":"Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells","volume":"447","author":"Jeong","year":"2019","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.biopha.2024.116271_bib150","first-page":"3799","article-title":"Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent","volume":"31","author":"Sreevalsan","year":"2011","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib151","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/biom9080302","article-title":"Cannabidiol induces cell cycle arrest and cell apoptosis in human gastric cancer SGC-7901 Cells","volume":"9","author":"Zhang","year":"2019","journal-title":"Biomolecules"},{"issue":"21","key":"10.1016\/j.biopha.2024.116271_bib152","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.3390\/ijms21218035","article-title":"Cannabinoids inhibited pancreatic cancer via P-21 activated kinase 1 mediated pathway","volume":"21","author":"Yang","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib153","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/can.2019.0081","article-title":"Cannabidiol treatment results in a common gene expression response across aggressive cancer cells from various origins","volume":"6","author":"Desprez","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"issue":"9","key":"10.1016\/j.biopha.2024.116271_bib154","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.3390\/s20092632","article-title":"Electrochemical assessment of anticancer compounds on the human tongue squamous carcinoma cells","volume":"20","author":"Huang","year":"2020","journal-title":"Sensors"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/jpet.116.236968","article-title":"Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability of glioblastoma and neural progenitor cells in culture","volume":"360","author":"Deng","year":"2017","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2024.116271_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.725136","article-title":"Cannabidiol induces apoptosis and perturbs mitochondrial function in human and canine glioma cells","volume":"12","author":"Gross","year":"2021","journal-title":"Front Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib157","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.103.061002","article-title":"Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines","volume":"308","author":"Massi","year":"2004","journal-title":"J. Pharm. Exp. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2024.116271_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076918","article-title":"A non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect","volume":"8","author":"Solinas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.116271_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105876","article-title":"Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER+ breast cancer cells: Impact on aromatase and steroid receptors","volume":"210","author":"Amaral","year":"2021","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib160","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.molonc.2014.12.010","article-title":"Modulation of the tumor microenvironment and inhibition of EGF\/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer","volume":"9","author":"Elbaz","year":"2015","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib161","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12906-016-1280-0","article-title":"Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells","volume":"16","author":"Lukhele","year":"2016","journal-title":"BMC Complement Alter. Med"},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228909","article-title":"Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro","volume":"15","author":"Milian","year":"2020","journal-title":"PLoS One"},{"issue":"7-8","key":"10.1016\/j.biopha.2024.116271_bib163","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/1947601912466556","article-title":"Cannabidiol inhibits growth and Induces programmed cell death in Kaposi Sarcoma\u2013associated herpesvirus-infected endothelium","volume":"3","author":"Maor","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.biopha.2024.116271_bib164","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fphar.2019.00430","article-title":"Modulation of the endocannabinoid system as a potential anticancer strategy","volume":"10","author":"Ramer","year":"2019","journal-title":"Front Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib165","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/ijc.29573","article-title":"Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner","volume":"137","author":"Nabissi","year":"2015","journal-title":"Int J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib166","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/03602532.2018.1428344","article-title":"Targeting the endocannabinoid system as a potential anticancer approach","volume":"50","author":"Schwarz","year":"2018","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib167","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbrc.2017.09.001","article-title":"Cannabidiol, a novel inverse agonist for GPR12","volume":"493","author":"Brown","year":"2017","journal-title":"Biochem Biophys. Res Commun."},{"issue":"10","key":"10.1016\/j.biopha.2024.116271_bib168","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/bph.14426","article-title":"Anti-tumour actions of cannabinoids","volume":"176","author":"Hinz","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116271_bib169","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/jm201139r","article-title":"Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery","volume":"55","author":"Melancon","year":"2012","journal-title":"J. Med Chem."},{"issue":"6","key":"10.1016\/j.biopha.2024.116271_bib170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/cpt.115","article-title":"Medicinal chemistry of cannabinoids","volume":"97","author":"Vemuri","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2024.116271_bib171","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.20120242","article-title":"Cannabinoids suppress inflammatory and neuropathic pain by targeting \u03b13 glycine receptors","volume":"209","author":"Xiong","year":"2012","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.biopha.2024.116271_bib172","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejp.818","article-title":"Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis","volume":"20","author":"Hammell","year":"2016","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.biopha.2024.116271_bib173","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1744-8069-5-49","article-title":"Tumor necrosis factor-alpha (TNF-alpha) enhances functional thermal and chemical responses of TRP cation channels in human synoviocytes","volume":"5","author":"Kochukov","year":"2009","journal-title":"Mol. Pain."},{"key":"10.1016\/j.biopha.2024.116271_bib174","series-title":"Handbook of Cannabis","first-page":"280","article-title":"Non-Phytocannabinoid constituents of cannabis and Herbal Synergy","volume":"1","author":"Pertwee","year":"2014"},{"key":"10.1016\/j.biopha.2024.116271_bib175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopen.2017.09.001","article-title":"Comparison of antimicrobial activities of natural essential oils and synthetic fragrances against selected environmental pathogens","volume":"5","author":"Vieira-Brock","year":"2017","journal-title":"Biochim Open"},{"issue":"10","key":"10.1016\/j.biopha.2024.116271_bib176","first-page":"600","article-title":"Biomaterials for bone defect repair and bone regeneration","volume":"52","author":"Jiang","year":"2017","journal-title":"Chin. J. Stomatol"},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib177","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cmet.2009.07.006","article-title":"Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells","volume":"10","author":"Idris","year":"2009","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib178","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11914-020-00607-1","article-title":"The cannabinoids effect on bone formation and bone healing","volume":"18","author":"Raphael-Mizrahi","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.biopha.2024.116271_bib179","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2017.05.011","article-title":"Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury","volume":"809","author":"Li","year":"2017","journal-title":"Eur. J. Pharm."},{"issue":"30","key":"10.1016\/j.biopha.2024.116271_bib180","first-page":"4867","article-title":"Cannabidiol promotes proliferation and osteogenic differentiation of human periodontal ligament stem cells","volume":"26","author":"Li","year":"2022","journal-title":"Chi Tis Eng. Res"},{"key":"10.1016\/j.biopha.2024.116271_bib181","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.msec.2019.03.070","article-title":"Cannabidiol-loaded microspheres incorporated into osteoconductive scaffold enhance mesenchymal stem cell recruitment and regeneration of critical-sized bone defects","volume":"101","author":"Kamali","year":"2019","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib182","doi-asserted-by":"crossref","first-page":"405","DOI":"10.15283\/ijsc21152","article-title":"Cannabidiol promotes osteogenic differentiation of bone marrow mesenchymal stem cells in the inflammatory microenvironment via the CB2-dependent p38 MAPK signaling pathway","volume":"15","author":"Li","year":"2022","journal-title":"Int J. Stem Cells"},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib183","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/ptr.6400","article-title":"Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury","volume":"33","author":"Sangiovanni","year":"2019","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib184","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/biom13010118","article-title":"Cannabidiol rescues TNF-\u03b1-inhibited proliferation, migration, and osteogenic\/odontogenic differentiation of dental pulp stem cells","volume":"13","author":"Yu","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.biopha.2024.116271_bib185","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jcb.25815","article-title":"Cannabidiol activates neuronal precursor genes in human gingival mesenchymal stromal cells","volume":"118","author":"Soundara Rajan","year":"2017","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.biopha.2024.116271_bib186","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ijbiomac.2022.09.013","article-title":"Cannabidiol-loaded injectable chitosan-based hydrogels promote spinal cord injury repair by enhancing mitochondrial biogenesis","volume":"221","author":"Zhang","year":"2022","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2024.116271_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112560","article-title":"Cannabidiol-containing alginate based hydrogel as novel multifunctional wound dressing for promoting wound healing","volume":"134","author":"Zheng","year":"2022","journal-title":"Biomater. Adv."},{"issue":"12","key":"10.1016\/j.biopha.2024.116271_bib188","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/tox.22996","article-title":"Cannabidiol induces osteoblast differentiation via angiopoietin1 and p38 MAPK","volume":"35","author":"Kang","year":"2020","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.biopha.2024.116271_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112339","article-title":"Development and characterization of cannabidiol-loaded alginate copper hydrogel for repairing open bone defects in vitro","volume":"212","author":"Qi","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib190","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/pharmaceutics14081637","article-title":"Fabrication and preliminary in vitro evaluation of 3D-printed alginate films with cannabidiol (CBD) and cannabigerol (CBG) nanoparticles for potential wound-healing applications","volume":"14","author":"Monou","year":"2022","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.biopha.2024.116271_bib191","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1111\/bph.15157","article-title":"The potential of cannabidiol in the COVID-19 pandemic","volume":"177","author":"Esposito","year":"2020","journal-title":"Br. J. Pharm."},{"issue":"22","key":"10.1016\/j.biopha.2024.116271_bib192","first-page":"22425","article-title":"In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.biopha.2024.116271_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114293","article-title":"Advances and future perspectives in epithelial drug delivery","volume":"186","author":"Mohammed","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib194","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0090-9556(25)06962-4","article-title":"Pharmacokinetics of cannabidiol in dogs","volume":"16","author":"Samara","year":"1998","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib195","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40263-020-00741-5","article-title":"Critical aspects affecting cannabidiol oral bioavailability and metabolic elimination, and related clinical implications","volume":"34","author":"Perucca","year":"2020","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.biopha.2024.116271_bib196","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.xphs.2021.08.012","article-title":"Improved bioavailability with dry powder cannabidiol inhalation: a phase 1 clinical study","volume":"110","author":"Devinsky","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.116271_bib197","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2018.09.003","article-title":"Challenges and innovations of drug delivery in older age","volume":"135","author":"Khan","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.116271_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2019.103202","article-title":"Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model","volume":"70","author":"Xu","year":"2019","journal-title":"Environ. Toxicol. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib199","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000489034","article-title":"Human pharmacokinetics and adverse effects of pulmonary and intravenous THC-CBD formulations","volume":"1","author":"Meyer","year":"2018","journal-title":"Med Cannabis Cannabinoids"},{"issue":"9","key":"10.1016\/j.biopha.2024.116271_bib200","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3109\/03639041003657295","article-title":"Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers","volume":"36","author":"Paudel","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib201","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/bms.1200130206","article-title":"Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration","volume":"13","author":"Ohlsson","year":"1986","journal-title":"Biomed. Environ. Mass Spectrom."},{"key":"10.1016\/j.biopha.2024.116271_bib202","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2013.08.011","article-title":"Oral transmucosal drug delivery for pediatric use","volume":"73","author":"Lam","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.116271_bib203","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.addr.2020.10.018","article-title":"Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic","volume":"160","author":"Lam","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2024.116271_bib204","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br. J. Clin. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib205","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/bcp.14617","article-title":"A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single-dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers","volume":"87","author":"Hosseini","year":"2021","journal-title":"Br. J. Clin. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib206","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040691","article-title":"Drug nanocrystals: focus on brain delivery from therapeutic to diagnostic applications","volume":"14","author":"Zingale","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib207","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/pharmaceutics14020438","article-title":"The transdermal delivery of therapeutic cannabinoids","volume":"14","author":"Mahmoudinoodezh","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.116271_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.899940","article-title":"Pharmacokinetics of cannabidiol following intranasal, intrarectal, and oral administration in healthy dogs","volume":"9","author":"Polidoro","year":"2022","journal-title":"Front Vet. Sci."},{"key":"10.1016\/j.biopha.2024.116271_bib209","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.626882","article-title":"Design and application in delivery system of intranasal antidepressants","volume":"8","author":"Xu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116271_bib210","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","article-title":"Intranasal treatment of central nervous system dysfunction in humans","volume":"30","author":"Chapman","year":"2013","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib211","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/17425247.2022.2074975","article-title":"Recent advances in drug delivery to the central nervous system by inhalation","volume":"19","author":"Tai","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib212","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010031","article-title":"Dry powder for pulmonary delivery: a comprehensive review","volume":"13","author":"Chaurasiya","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib213","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jat\/bkz080","article-title":"Urinary pharmacokinetic profile of cannabinoids following administration of vaporized and oral cannabidiol and vaporized CBD-dominant cannabis","volume":"44","author":"Spindle","year":"2020","journal-title":"J. Anal. Toxicol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116271_bib214","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/1389203721999201111195512","article-title":"Current updates in transdermal therapeutic systems and their role in neurological disorders","volume":"22","author":"Yadav","year":"2021","journal-title":"Curr. Protein Pept. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib215","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jconrel.2003.09.001","article-title":"Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model","volume":"93","author":"Lodzki","year":"2002","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.116271_bib216","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/vjch.202100012","article-title":"Study on synthesizing silver nanoparticles by using Muntingia calabura leaf extract: Insights from experimental and theoretical studies","volume":"59","author":"Tan Trung","year":"2021","journal-title":"Vietnam J. Chem."},{"key":"10.1016\/j.biopha.2024.116271_bib217","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/pharmaceutics11050217","article-title":"Modifications in vaginal microbiota and their influence on drug release: challenges and opportunities","volume":"11","author":"Leyva-G\u00f3mez","year":"2019","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib218","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/156720108785914970","article-title":"Mucoadhesive microspheres: a promising tool in drug delivery","volume":"5","author":"Patil","year":"2008","journal-title":"Curr Drug Deliv"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib220","first-page":"693","article-title":"Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women","volume":"72","author":"Vermesh","year":"1988","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116271_bib221","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/humupd\/5.4.365","article-title":"Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus","volume":"5","author":"Cicinelli","year":"1999","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib222","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/adb.12495","article-title":"Cannabidiol reduces ethanol consumption, motivation and relapse in mice","volume":"23","author":"Viudez-Martinez","year":"2018","journal-title":"Addict. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib223","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0736-4679(90)90225-K","article-title":"The administration of rectal diazepam for acute management of seizures","volume":"8","author":"Seigler","year":"1990","journal-title":"J. Emerg. Med."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib224","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.ijg.0000212260.04488.60","article-title":"Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study","volume":"15","author":"Tomida","year":"2006","journal-title":"J. Glaucoma"},{"issue":"S5","key":"10.1016\/j.biopha.2024.116271_bib225","first-page":"1","article-title":"Cannabidiol signaling in the eye and its potential as an ocular therapeutic agent","volume":"55","author":"Aebersold","year":"2021","journal-title":"Cell Physiol. Biochem"},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib226","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jps.2600720210","article-title":"Systemic absorption of delta 9-tetrahydrocannabinol after ophthalmic administration to the rabbit","volume":"72","author":"Chiang","year":"1983","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2024.116271_bib227","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/jop.2019.0135","article-title":"Novel ocular drug delivery systems: an update on microemulsions","volume":"36","author":"\u00dcst\u00fcnda\u011f Okur","year":"2020","journal-title":"J. Ocul. Pharm. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2024.116271_bib228","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.biopha.2024.116271_bib229","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2174\/138920010794479673","article-title":"Disposition of nanoparticle-based delivery system via inner ear administration","volume":"11","author":"Chen","year":"2010","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib230","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2015.08.015","article-title":"Recent advances in local drug delivery to the inner ear","volume":"494","author":"Kechai","year":"2015","journal-title":"Int J. Pharm."},{"issue":"44","key":"10.1016\/j.biopha.2024.116271_bib231","doi-asserted-by":"crossref","first-page":"2008701","DOI":"10.1002\/adfm.202008701","article-title":"Drug delivery across barriers to the middle and inner ear","volume":"31","author":"Zhang","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"11","key":"10.1016\/j.biopha.2024.116271_bib232","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/000348949009901113","article-title":"Titration streptomycin therapy for bilateral Meni\u00e9re's disease. Follow-up report","volume":"99","author":"Langman","year":"1990","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.biopha.2024.116271_bib233","doi-asserted-by":"crossref","DOI":"10.1016\/j.jevs.2021.103842","article-title":"Pharmacokinetic evaluation of a cannabidiol supplement in horses","volume":"110","author":"Williams","year":"2022","journal-title":"J. Equine Vet. Sci."},{"key":"10.1016\/j.biopha.2024.116271_bib234","first-page":"9","article-title":"Plasma pharmacokinetics of cannabidiol following oral administration of cannabidiol oil to dairy calves","author":"Meyer","year":"2022","journal-title":"Front Vet. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2024.116271_bib235","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopha.2024.116271_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.jevs.2022.103933","article-title":"Pharmacokinetics, safety, and synovial fluid concentrations of single- and multiple-dose oral administration of 1 and 3 mg\/kg cannabidiol in horses","author":"Yocom","year":"2022","journal-title":"J. Equine Vet. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2024.116271_bib237","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/jvp.13026","article-title":"Plasma and joint tissue pharmacokinetics of two doses of oral cannabidiol oil in guinea pigs (Cavia porcellus)","volume":"44","author":"Spittler","year":"2021","journal-title":"J. Vet. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib238","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10787-021-00859-y","article-title":"A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study","volume":"29","author":"Vitetta","year":"2021","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib239","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10787-021-00859-y","article-title":"A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study","volume":"29","author":"Vitetta","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2024.116271_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113929","article-title":"Topical drug delivery: History, percutaneous absorption, and product development","volume":"177","author":"Roberts","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"46","key":"10.1016\/j.biopha.2024.116271_bib241","doi-asserted-by":"crossref","first-page":"19306","DOI":"10.1039\/D0NR03872E","article-title":"Silver chalcogenide nanoparticles: a review of their biomedical applications","volume":"13","author":"Nieves","year":"2021","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib242","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/neuonc\/now155","article-title":"Long-term survival in AIDS-related primary central nervous system lymphoma","volume":"19","author":"Gupta","year":"2017","journal-title":"Neurol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib243","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1152\/jappl.1990.69.1.362","article-title":"Mathematical modeling of heat and water transport in human respiratory tract","volume":"69","author":"Daviskas","year":"1990","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.biopha.2024.116271_bib244","series-title":"Inhalation Drug Delivery: Techniques and Products","article-title":"Inhalation drug delivery","author":"Traini","year":"2013"},{"key":"10.1016\/j.biopha.2024.116271_bib245","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/OPTH.S118409","article-title":"Systemic side effects of eye drops: a pharmacokinetic perspective","volume":"10","author":"Farkouh","year":"2016","journal-title":"Clin. Ophthalmol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116271_bib246","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.3390\/ijms24119693","article-title":"Cannabidiol for oral health: a new promising therapeutical tool in dentistry","volume":"24","author":"Bellocchio","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.biopha.2024.116271_bib247","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.5897\/AJMR2015.7457","article-title":"Oral microflora of supragingival and subgingival biofilms in Algerian healthy adults","volume":"9","author":"Sara","year":"2015","journal-title":"Afr. J. Microbiol Res"},{"key":"10.1016\/j.biopha.2024.116271_bib248","first-page":"11","article-title":"Oral biofilms: molecular analysis, challenges, and future prospects in dental diagnostics","volume":"5","author":"Do","year":"2013","journal-title":"Clin. Cosmet. Invest. Dent."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib249","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5507\/bp.2022.012","article-title":"Cannabidiol and periodontal inflammatory disease: a critical assessment","volume":"166","author":"Jirasek","year":"2022","journal-title":"Biomed. Pap. Med Fac. Univ. Palacky. Olomouc Czech Repub."},{"issue":"10","key":"10.1016\/j.biopha.2024.116271_bib250","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/dj10100193","article-title":"Cannabidiol in dentistry: a scoping review","volume":"10","author":"David","year":"2022","journal-title":"Dent. J. (Basel)"},{"key":"10.1016\/j.biopha.2024.116271_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119812","article-title":"Cannabidiol aqueous solubility enhancement: comparison of three amorphous formulations strategies using different type of polymers","volume":"589","author":"Koch","year":"2020","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.biopha.2024.116271_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116070","article-title":"Inclusion complexes of cannabidiol with \u03b2-cyclodextrin and its derivative: physicochemical properties, water solubility, and antioxidant activity","volume":"334","author":"Li","year":"2021","journal-title":"J. Mol. Liq."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib253","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jps.20766","article-title":"Precipitation complexation method produces cannabidiol\/beta-cyclodextrin inclusion complex suitable for sublingual administration of cannabidiol","volume":"96","author":"Mannila","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.116271_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119812","article-title":"Cannabidiol aqueous solubility enhancement: comparison of three amorphous formulations strategies using different type of polymers","volume":"589","author":"Koch","year":"2020","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.biopha.2024.116271_bib255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119812","article-title":"Cannabidiol aqueous solubility enhancement: comparison of three amorphous formulations strategies using different type of polymers","volume":"589","author":"Koch","year":"2020","journal-title":"Int J. Pharm."},{"issue":"16","key":"10.1016\/j.biopha.2024.116271_bib256","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24162967","article-title":"A novel self-emulsifying drug delivery system (SEDDS) based on VESIsorb((R)) formulation technology improving the oral bioavailability of cannabidiol in healthy subjects","volume":"24","author":"Knaub","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116271_bib257","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121159","article-title":"Lipid-based formulations to increase cannabidiol bioavailability: in vitro digestion tests, pre-clinical assessment and clinical trial","volume":"609","author":"De Pra","year":"2021","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.biopha.2024.116271_bib258","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106058","article-title":"Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol","volume":"168","author":"Kok","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.116271_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119201","article-title":"The effect of medium chain and long chain triglycerides incorporated in self-nano emulsifying drug delivery systems on oral absorption of cannabinoids in rats","volume":"580","author":"Izgelov","year":"2020","journal-title":"Int J. Pharm."},{"issue":"18","key":"10.1016\/j.biopha.2024.116271_bib260","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27186070","article-title":"Promising nanocarriers to enhance solubility and bioavailability of cannabidiol for a plethora of therapeutic opportunities","volume":"27","author":"Grifoni","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib261","doi-asserted-by":"crossref","DOI":"10.3390\/foods11030376","article-title":"Enhanced stability and oral bioavailability of cannabidiol in zein and whey protein composite nanoparticles by a modified anti-solvent approach","volume":"11","author":"Wang","year":"2022","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.biopha.2024.116271_bib262","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000497361","article-title":"Development of a novel nano-emulsion formulation to improve intestinal absorption of cannabidiol","volume":"2","author":"Nakano","year":"2019","journal-title":"Med Cannabis Cannabinoids"},{"issue":"5","key":"10.1016\/j.biopha.2024.116271_bib263","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11095-023-03469-1","article-title":"Cannabidiol for the treatment of brain disorders: therapeutic potential and routes of administration","volume":"40","author":"Yau","year":"2023","journal-title":"Pharm. Res"},{"issue":"9","key":"10.1016\/j.biopha.2024.116271_bib264","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1080\/10717544.2016.1177136","article-title":"Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape","volume":"23","author":"Zylberberg","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2024.116271_bib265","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2147\/DDDT.S264648","article-title":"Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages","volume":"14","author":"Ghasemiyeh","year":"2020","journal-title":"Drug Des. Devel Ther."},{"issue":"2","key":"10.1016\/j.biopha.2024.116271_bib266","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13205-014-0214-0","article-title":"Nanoemulsion: an advanced mode of drug delivery system","volume":"5","author":"Jaiswal","year":"2015","journal-title":"3 Biotech"},{"key":"10.1016\/j.biopha.2024.116271_bib267","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587997","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Scioli Montoto","year":"2020","journal-title":"Front Mol. Biosci."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116271_bib268","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"M\u00fcller","year":"2002","journal-title":"Int J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2024.116271_bib269","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-2494.2008.00433.x","article-title":"Cosmetic features and applications of lipid nanoparticles (SLN, NLC)","volume":"30","author":"Souto","year":"2018","journal-title":"Int J. Cosmet. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:06:08Z","timestamp":1781651168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224001525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":269,"alternative-id":["S0753332224001525"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116271","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116271"}}